|
1
|
Slominski AT, Kim TK, Li W, Postlethwaite
A, Tieu EW, Tang EK and Tuckey RC: Detection of novel
CYP11A1-derived secosteroids in the human epidermis and serum and
pig adrenal gland. Sci Rep. 5:148752015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naan EC, Kirpensteijn J, Dupré GP, Galac S
and Radlinsky MG: Innovative approach to laparoscopic adrenalectomy
for treatment of unilateral adrenal gland tumors in dogs. Vet Surg.
42:710–715. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Li F, Chen D, Zhu Y, He C, Du Y
and Tan W: Retroperitoneal versus transperitoneal laparoscopic
adrenalectomy in adrenal tumor: A meta-analysis. Surg Laparosc
Endosc Percutan Tech. 23:121–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libé R, Borget I, Ronchi CL, Zaggia B,
Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O,
et al: ENSAT network: Prognostic factors in stage III–IV
adrenocortical carcinomas (ACC): An European Network for the Study
of Adrenal Tumor (ENSAT) study. Ann Oncol. 26:2119–2125. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahmed M: Technology Assessment Committee
of the Society of Interventional Radiology: Image-guided tumor
ablation: standardization of terminology and reporting criteria - a
10-year update: Supplement to the consensus document. J Vasc Interv
Radiol. 25:1706–1708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan
J, Townsend DW, Budgeon CA, Boucek JA, Francis RJ, Cheo TST, et al:
Post-radioembolization yttrium-90 PET/CT - part 2: Dose-response
and tumor predictive dosimetry for resin microspheres. EJNMMI Res.
3:57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uppot RN and Gervais DA: Imaging-guided
adrenal tumor ablation. AJR Am J Roentgenol. 200:1226–1233. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ell B, Mercatali L, Ibrahim T, Campbell N,
Schwarzenbach H, Pantel K, Amadori D and Kang Y: Tumor-induced
osteoclast miRNA changes as regulators and biomarkers of osteolytic
bone metastasis. Cancer Cell. 24:542–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Kong X, Li J, Luo Q, Li X, Shen
L, Chen L and Fang L: miR-96 promotes tumor proliferation and
invasion by targeting RECK in breast cancer. Oncol Rep.
31:1357–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng J, Yu J, Pan X, Li Z, Chen Z, Zhang
W, Wang B, Yang L, Xu H, Zhang G, et al: HERG1 functions as an
oncogene in pancreatic cancer and is downregulated by miR-96.
Oncotarget. 5:5832–5844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilson JM, Christianson OI, Richard S and
Samei E: A methodology for image quality evaluation of advanced CT
systems. Med Phys. 40:0319082013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donatini G, van Slycke S, Aubert S and
Carnaille B: Corticomedullary mixed tumor of the adrenal gland-a
clinical and pathological chameleon: case report and review of
literature. Updates Surg. 65:161–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawano K, Hattori Y, Iwakura H, Akamizu T
and Maitani Y: Combination therapy with gefitinib and doxorubicin
inhibits tumor growth in transgenic mice with adrenal
neuroblastoma. Cancer Med. 2:286–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu D, He X, Chang Y, Xu C, Jiang X, Sun S
and Lin J: Inhibition of miR-96 expression reduces cell
proliferation and clonogenicity of HepG2 hepatoma cells. Oncol Rep.
29:653–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Luo H, Li Y, Chen T, Wu S and Yang
L: hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a
promising diagnostic marker in human bladder urothelial carcinomas.
Mol Med Rep. 5:260–265. 2012.PubMed/NCBI
|
|
18
|
Li P, Sheng C, Huang L, Zhang H, Huang L,
Cheng Z and Zhu Q: MiR-183/-96/-182 cluster is up-regulated in most
breast cancers and increases cell proliferation and migration.
Breast Cancer Res. 16:4732014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandel R, Das A, Chawla YK and Kaur J:
Mo1477: Progression of hepatocellular carcinoma is associated with
the up rregulation of rno-miR-96/182/183 cluster in liver of Wistar
rats. Gastroenterology. 150(Suppl 1): S11252016. View Article : Google Scholar
|
|
20
|
Hensley CT, Faubert B, Yuan Q, Lev-Cohain
N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, et al:
Metabolic heterogeneity in human lung tumors. Cell. 164:681–694.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mall C, Rocke DM, Durbin-Johnson B and
Weiss RH: Stability of miRNA in human urine supports its biomarker
potential. Biomarkers Med. 7:623–631. 2013. View Article : Google Scholar
|
